Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574886 · ClinicalTrials.gov registry record · NA

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

A NA study of Lymphoma, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
2
Enrollment target
1
Study location

NCT00574886 is a NA study of Lymphoma that has completed, run by University of Nebraska. The registered enrollment target is 2 participants, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574886, a NA study of Lymphoma, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
2 participants
Enrollment target
1
Study location

Study Summary

This is a compassionate use protocol for participants who failed induction chemotherapy + Vaccine on previous trials. These participants then went on to high dose BEAM chemotherapy and transplant, then received idiotype vaccine therapy at 3 months post transplant. Vaccine was given monthly x 4 series, with a fifth series given 12 weeks after the fourth. Participants were then followed annually until progression or death with standard staging.

Conditions Studied

Lymphoma

Interventions

  • BIOLOGICAL Id-KLH

Study Locations (1)

Nebraska

  • Unversity of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2000-08-03
Est. Completion 2008-04-15
Phase NA

Sponsor

University of Nebraska

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00574886

The ClinicalTrials.gov registry entry for NCT00574886 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (100% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which Id-KLH is the first listed.

NCT00574886 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT00574886 about?

NCT00574886 is a clinical study titled "Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy". This is a compassionate use protocol for participants who failed induction chemotherapy + Vaccine on previous trials. These participants then went on to high dose BEAM chemotherapy and transplant, then received idiotype vaccine therapy at 3 months post transplant. Vaccine was given monthly x 4 serie...

What is the current status of trial NCT00574886?

This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2000-08-03. Estimated completion is 2008-04-15.

What conditions does trial NCT00574886 study?

This clinical trial studies the following conditions: Lymphoma.

What interventions are being tested in trial NCT00574886?

The interventions under investigation include: Id-KLH (BIOLOGICAL).

Who is sponsoring clinical trial NCT00574886?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00574886 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lymphoma

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.